Jenscare Scientific Widens Loss in 2025; Shares Soar 6%
MT Newswires Live
Mar 27
Jenscare Scientific (HKG:9877) widened its attributable loss for the year 2025 to 271.2 million yuan from 177.5 million yuan a year prior, according to a Thursday Hong Kong bourse filing.
Shares of the medical device company were up nearly 6% in Friday afternoon trading.
Loss per share stood at 0.64 yuan in the fiscal year, compared with 0.43 yuan in the previous corresponding year.
Revenue stood at 90.6 million yuan in the period, whereas the firm did not record a revenue for the previous year.
The revenue was attributed to a higher sales volume resulting from the commercialization of its interventional products for the treatment of structural heart diseases.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.